These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22884553)

  • 21. Inflammasome and cytokine blocking strategies in autoinflammatory disorders.
    Moll M; Kuemmerle-Deschner JB
    Clin Immunol; 2013 Jun; 147(3):242-75. PubMed ID: 23697917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoinflammatory diseases in pediatrics.
    Hausmann JS; Dedeoglu F
    Dermatol Clin; 2013 Jul; 31(3):481-94. PubMed ID: 23827250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familial Mediterranean fever and related periodic fever syndromes/autoinflammatory diseases.
    Savic S; Dickie LJ; Battellino M; McDermott MF
    Curr Opin Rheumatol; 2012 Jan; 24(1):103-12. PubMed ID: 22089100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The fresco of autoinflammatory diseases from the pediatric perspective.
    Rigante D
    Autoimmun Rev; 2012 Mar; 11(5):348-56. PubMed ID: 22024500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hereditary periodical fever syndromes].
    Herlin T; Sørensen N; Veirum J
    Ugeskr Laeger; 2011 Mar; 173(13):968-73. PubMed ID: 21453638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Introduction to autoinflammatory syndromes and diseases.
    Abramovits W; Oquendo M
    Dermatol Clin; 2013 Jul; 31(3):363-85. PubMed ID: 23827242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific increase in caspase-1 activity and secretion of IL-1 family cytokines: a putative link between mevalonate kinase deficiency and inflammation.
    Normand S; Massonnet B; Delwail A; Favot L; Cuisset L; Grateau G; Morel F; Silvain C; Lecron JC
    Eur Cytokine Netw; 2009 Sep; 20(3):101-7. PubMed ID: 19825518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Autoinflammatory syndromes in dermatology].
    Feldmeyer L
    Rev Med Suisse; 2012 Apr; 8(335):756-8, 760-1. PubMed ID: 22545497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Comprehensive Overview of the Hereditary Periodic Fever Syndromes.
    Rigante D; Frediani B; Cantarini L
    Clin Rev Allergy Immunol; 2018 Jun; 54(3):446-453. PubMed ID: 27068928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A dermatologic perspective on autoinflammatory diseases.
    Marzano AV; Damiani G; Genovese G; Gattorno M
    Clin Exp Rheumatol; 2018; 36 Suppl 110(1):32-38. PubMed ID: 29742056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoinflammatory syndromes behind the scenes of recurrent fevers in children.
    Rigante D
    Med Sci Monit; 2009 Aug; 15(8):RA179-87. PubMed ID: 19644432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoinflammatory syndromes.
    Galeazzi M; Gasbarrini G; Ghirardello A; Grandemange S; Hoffman HM; Manna R; Podswiadek M; Punzi L; Sebastiani GD; Touitou I; Doria A
    Clin Exp Rheumatol; 2006; 24(1 Suppl 40):S79-85. PubMed ID: 16466630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brief Report: Involvement of TNFRSF11A molecular defects in autoinflammatory disorders.
    Jéru I; Cochet E; Duquesnoy P; Hentgen V; Copin B; Mitjavila-Garcia MT; Sheykholeslami S; Le Borgne G; Dastot-Le Moal F; Malan V; Karabina S; Mahevas M; Chantot-Bastaraud S; Lecron JC; Faivre L; Amselem S
    Arthritis Rheumatol; 2014 Sep; 66(9):2621-7. PubMed ID: 24891336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumour necrosis factor receptor-associated periodic syndrome (TRAPS): state of the art and future perspectives.
    Cantarini L; Lucherini OM; Muscari I; Frediani B; Galeazzi M; Brizi MG; Simonini G; Cimaz R
    Autoimmun Rev; 2012 Nov; 12(1):38-43. PubMed ID: 22884554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and biochemical landmarks in systemic autoinflammatory diseases.
    Cantarini L; Rigante D; Brizi MG; Lucherini OM; Sebastiani GD; Vitale A; Gianneramo V; Galeazzi M
    Ann Med; 2012 Nov; 44(7):664-73. PubMed ID: 21972825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Real-Life Indications of Interleukin-1 Blocking Agents in Hereditary Recurrent Fevers: Data From the JIRcohort and a Literature Review.
    Vinit C; Georgin-Lavialle S; Theodoropoulou A; Barbier C; Belot A; Mejbri M; Pillet P; Pachlopnik J; Poignant S; Rebelle C; Woerner A; Koné-Paut I; Hentgen V
    Front Immunol; 2021; 12():744780. PubMed ID: 34858402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic autoinflammation with intractable epilepsy managed with interleukin-1 blockade.
    DeSena AD; Do T; Schulert GS
    J Neuroinflammation; 2018 Feb; 15(1):38. PubMed ID: 29426321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytokine signatures in hereditary fever syndromes (HFS).
    Ibrahim JN; Jéru I; Lecron JC; Medlej-Hashim M
    Cytokine Growth Factor Rev; 2017 Feb; 33():19-34. PubMed ID: 27916611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current treatment options for monogenic periodic fever syndromes - the role of interleukin 1 inhibitors.
    Milota T; Malcová H; Střížová Z; Cebecauerová D; Horváth R
    Cas Lek Cesk; 2022; 161(1):3-10. PubMed ID: 35354288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Fever of unknown cause and autoinflammatory disease].
    Hara T
    Nihon Rinsho; 2011 Sep; 69(9):1679-89. PubMed ID: 21922774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.